SCHEMBL20151019

SCHEMBL20151019

c1cc(-c2ccc3c(c2)c2ccccc2n3-c2nc3ccccc3c3nc4ccccc4n23)cc(-n2c3ccccc3c3ccccc32)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.49
HPGD P15428 6/20 0.49
ALDH1A1 P00352 4/20 0.49
KMT2A Q03164 5/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MAPT P10636 4/20 0.44
POLB P06746 2/20 0.44
HSD17B10 Q99714 2/20 0.44
LMNA P02545 1/20 0.44
TP53 P04637 1/20 0.44
MEN1 O00255 4/20 0.41
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
GAA P10253 2/20 0.36
HIF1A Q16665 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CASP1 P29466 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20151034 0.95 KDM4E (0.49) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20041864 0.94 KDM4E (0.49) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151426 0.94 KDM4E (0.49) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151020 0.93 KDM4E (0.49) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151466 0.93 KDM4E (0.52) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151037 0.93 KDM4E (0.48) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151473 0.92 KDM4E (0.49) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151024 0.92 KDM4E (0.49) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151044 0.92 KDM4E (0.50) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151060 0.92 KDM4E (0.50) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11031560-B2 Compound and organic electronic element comprising same LG CHEM, LTD. (KR) 2021-06-08 US disclosed
US-20180138422-A1 COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-17 US disclosed
US-20180138422-A1 COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11031560-B2 Compound and organic electronic element comprising same OR10J3, ESR1, ETV6 KDM4E 847/4885HPGD 4158/4885ALDH1A1 1081/4885
US-20180138422-A1 COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME OR10J3, ESR1, ETV6 KDM4E 847/4885HPGD 4158/4885ALDH1A1 1081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.